What it is
Tesamorelin is a synthetic growth-hormone-releasing-hormone analogue. It holds regulatory approval in some jurisdictions for a specific prescription indication; approval does not extend to general wellness or body-composition use.
The Range
IPA · Pen · Endocrine research
Tesamorelin 5 mg pen
Approved medicineEvidence: Established
A GHRH analogue approved in certain markets for a specific, narrowly defined clinical indication under prescription and specialist oversight.
Evidence highlights
Mechanism being studied
Stimulates endogenous growth-hormone release via GHRH receptor agonism.
Human evidence
Randomised controlled trials support its approved indication in the populations studied. Evidence outside that approved indication is limited and does not support general use.
Information only — availability subject to applicable law, prescription/authorisation, and licensed healthcare/pharmacy channels. Nothing on this page is an offer to sell, and no dosing or self-administration guidance is provided.
South Africa — compliance notice
SAHPRA has publicly warned about unregistered peptide products being marketed to the South African public. In general, products intended to diagnose, treat, or otherwise alter bodily functions require registration or authorisation before they may lawfully be sold. ELLIVON BIOSCIENCES publishes reference information only and directs all clinical questions to registered healthcare professionals and licensed pharmacy channels.